5
(1:1:98 then 10:1:89, ether:Et3N:light petroleum) of a sample
12.1, 9.6, 5.3, CHHCH2Si), 3.66-3.73 (1H, m, 7-H), 3.73-3.81
ACCEPTED MANUSCRIPT
gave the title compound 8 (86%), Rf = 0.18 (1:9, ether:light
(1H, m, 5-H), 4.13 (1H, dq, J 4.7, 6.2, 8-H), 4.38-4.46 (3H, m, 1-
H2, OHCHO) 4.52 (1H, d, J 6.8, OHCHO), 5.84 (1H, t, J 5.7, 2-
H), 7.25-7.46 (12H, m, ArH), 7.62-7.78 (8H, m, ArH); δC −1.2,
4.1, 5.2, 10.1, 14.4, 18.2, 18.4, 19.2, 27.2, 27.3, 27.5, 29.2, 36.5,
41.9, 61.1, 65.5, 67.8, 70.5, 79.4, 96.4, 127.7, 128.0, 129.7,
129.9, 134.0, 134.2, 134.7, 135.8, 135.9, 136.1, 142.7, 143.1; m/z
(ES+) 1143 (28%), 364 (50), 332 ( 100).
20
petroleum); [α]D −7.3 (c 1.2, CHCl3); νmax/cm-1 3449, 2955,
2927, 1725, 1659, 1462, 1425, 1378, 1247, 1105, 1058, 1032,
859, 834; δH −0.04 [9H, s, Si(CH3)3], 0.55-0.71 (1H, m, CHHSi),
0.66 (6H, q, J 7.6, 3
CHHSi), 0.87-1.04 (27H, m, 3
9-H3), 1.10 [9H, s, SiC(CH3)3], 1.28-1.43 (6H, m, 3
1.57 (7H, m, 3
2.16 (1H, dd, J 7.2, 4.6, OH), 2.47 (1H, dd, J 13.6, 7.7, 4-H),
2.73 (1H, dd, J 13.6, 6.3, 4-H ), 3.30 (1H, ddd, J 11.6, 9.8, 5.9,
× SiCH2), 0.80 (1H, ddd, J 13.7, 11.7, 5.7,
×
CH3, 3
×
CH2Sn, 3
×
SiCH2CH3,
×
CH2), 1.46-
×
CH2, 6-H), 1.80 (1H, ddd, J 13.6, 7.6, 1.6, 6-H′),
4.2.5
(2E,5R,7R,8R)-1-tert-Butyldimethylsilyloxy-8-tert-
butyldiphenylsilyloxy-3-iodo-5-triethylsilyloxy-7-(2-
′
trimethylsilylethoxymethoxy)non-2-ene (11). The stannane 9 (920
mg, 0.85 mmol) in DCM (9.8 mL) was added to a suspension of
N-iodosuccinimide (287 mg, 1.27 mmol) in DCM (5.9 mL) at rt
and the mixture stirred for 1.5 h. After concentration under
reduced pressure, chromatography (2:1:97, ether:Et3N:light
petroleum) of the residue gave the title compound 11 (746 mg,
96%), Rf = 0.45 (6% ether in light petroleum); νmax/cm-1 2955,
2930, 2879, 2858, 1466, 1426, 1377, 1256, 1105, 835, 777, 740;
CHHCH2Si), 3.51 (1H, ddd, J 11.8, 9.5, 5.3, CHHCH2Si), 3.70
(1H, ddd, J 10.0, 4.1, 2.1, 7-H), 3.89-3.96 (1H, m, 5-H), 4.07-
4.23 (2H, m, 1-H, 8-H), 4.36 (1H, ddd, J 12.7, 6.9, 4.6, 1-H′),
4.51 and 4.58 (each 1H, d, J 6.8, OHCHO), 5.95 (1H, t, J 6.3, 2-
H), 7.36-7.48 (6H, m, ArH), 7.68-7.75 (4H, m, ArH); δC −1.3,
5.7, 7.3, 10.0, 14.0, 16.8, 18.1, 19.5, 27.3, 27.8, 29.4, 35.5, 42.7,
46.4, 59.4, 65.2, 69.9, 79.9, 96.0, 127.7, 127.8, 129.8, 129.9,
134.2, 134.9, 136.1, 142.1, 144.4; m/z (ES+) 1064 (73%), 984
(100), 962 (40).
δH −0.02 (6H, s, 2
J 7.9, 3 SiCH2), 0.77-0.91 (2H, m, SiCH2), 0.94 (3H, d, J 5.9,
9-H3), 0.94 [9H, s, SiC(CH3)3], 1.01 (9H, t, J 7.9, 3 SiCH2CH3),
1.11 [9H, s, SiC(CH3)3], 1.61 (1H, ddd, J 14.1, 10.0, 5.2, 6-H),
1.89 (1H, ddd, J 14.1, 7.1, 1.7, 6-H ), 2.67 (2H, d, J 6.1, 4-H2),
× SiCH3), 0.12 [9H, s, Si(CH3)3], 0.68 (6H, q,
×
4.2.3
(2E,5R,7R,8R)-1-tert-Butyldimethylsilyloxy-8-tert-
×
butyldiphenylsilyloxy-3-tributylstannyl-5-triethylsilyloxy-7-(2-
trimethylsilylethoxymethoxy)non-2-ene (9). Alcohol 8 (1.09 g,
1.13 mmol) in DCM (2 mL) was added to tert-butyldimethylsilyl
chloride (205 mg, 1.36 mmol) and imidazole (184 mg, 2.71
′
3.41 (1H, ddd, J 11.5, 9.6, 5.9, CHHCH2Si), 3.54 (1H, ddd, J
11.7, 9.6, 5.4, CHHCH2Si), 3.65 (1H, ddd, J 10.0, 4.2, 1.4, 7-H),
4.03-4.18 (2H, m, 5-H, 8-H), 4.22 (2H, t, J 6.3, 1-H2), 4.54 and
4.60 (each 1H, d, J 6.8, OHCHO) 6.41 (1H, t, J 6.3, 2-H), 7.36-
7.49 (6H, m, ArH), 7.69-7.76 (4H, m, ArH); δC −4.9, −1.2, 5.6,
7.3, 16.9, 18.2, 19.5, 26.2, 27.3, 35.9, 48.6, 61.6, 65.5, 69.8, 70.1,
79.8, 96.0, 100.5, 127.7, 127.9, 128.6, 129.8, 129.9, 134.2, 134.8,
136.1, 136.1, 143.3; m/z (ES+) 973 (25%), 935 (M+ + 23, 100%);
HRMS (ES+): MNa+, found 935.3789. C43H77O5Si4INa requires
935.3785.
o
mmol) in DCM (2 mL) at 0 C and the mixture was stirred at rt
for 16 h. Saturated aqueous ammonium chloride was added and
the mixture partitioned between water and DCM. The aqueous
layer was extracted with DCM and the organic extracts were
dried MgSO4) and concentrated under reduced pressure.
Chromatography (1:1:98, ether:Et3N:light petroleum) of the
residue gave the title compound 9 (949 mg, 78% from 6), Rf =
20
0.58 (6% ether in light petroleum); [α]D +1.5 (c 1.3, CHCl3);
νmax/cm-1 2956, 2928, 2859, 1738, 1657, 1464, 1425, 1378, 1255,
4.2.6
(2E,5R,7R,8R)-1-tert-Butyldimethylsilyloxy-8-tert-
1104, 1058, 1036, 834, 776, 739; δH −0.05 (6H, s, 2
0.11 [9H, s, Si(CH3)3], 0.58 (1H, ddd, J 14.2, 11.8, 5.0, CHHSi),
0.65 (6H, q, J 8.2, 3 SiCH2), 0.77 (1H, ddd, J 14.0, 12.0, 5.6,
CHHSi) 0.84-1.04 (6H, m, 3 CH2Sn), 0.92 (9H, t, J 7.5, 3
CH3), 0.95 (3H, d, J 6.3, 9-H3), 0.96 [9H, s, SiC(CH3)3], 1.01
(9H, t, J 8.2, 3 SiCH2CH3), 1.10 [9H, s, SiC(CH3)3], 1.27-1.47
(7H, m, 3 CH2, 6-H), 1.44-1.69 (7H, m, 3 CH2, 6-H ), 2.47-
× SiCH3),
butyldiphenylsilyloxy-3-iodo-7-(2-
trimethylsilylethoxymethoxy)non-2-en-5-ol
(12)
and
×
(2E,5R,7R,8R)-8-tert-butyldiphenylsilyloxy-3-iodo-7-(2-
×
×
trimethylsilylethoxymethoxy)non-2-ene-1,5-diol (13). Hydrogen
fluoride (1% in MeCN, 1 mL) was added to the triethylsilyl ether
11 (90 mg, 99 µmol) in THF (0.5 mL) in a Teflon container at rt
and the mixture stirred for 1.5 h. Saturated aqueous sodium
hydrogen carbonate was added and the mixture partitioned
between water and EtOAc. The aqueous layer was extracted with
EtOAc and the organic extracts were dried (MgSO4) and
concentrated under reduced pressure. Chromatography (2:8 then
4:6 ether:light petroleum) of the residue gave the title compound
12 (20 mg, 25%), Rf = 0.81 (1:1, ether:light petroleum); νmax/cm-1
3464, 2954, 2929, 2893, 2858, 1467, 1632, 1427, 1376, 1255,
×
×
×
′
2.60 (2H, m, 4-H2), 3.26 (1H, ddd, J 9.5, 5.7, 3.6, CHHCH2Si),
3.51 (1H, ddd, J 9.1, 6.6, 4.2, CHHCH2Si), 3.74-3.81 (1H, m, 7-
H), 3.87-3.93 (1H, m, 5-H), 4.20 (1H, dq, J 6.2, 4.4, 8-H), 4.37
and 4.41 (each 1H, dd, J 13.8, 5.5, 1-H), 4.51 and 4.59 (each 1H,
d, J 6.8, OHCHO), 5.77 (1H, t, J 5.4, 2-H), 7.36-7.48 (6H, m,
ArH), 7.68-7.75 (4H, m, ArH); δC −4.7, −1.3, 1.3, 5.8, 7.4, 10.0,
14.0, 16.8, 18.1, 19.5, 26.3, 27.3, 27.8, 29.4, 35.1, 43.8, 61.1,
65.0, 69.3, 69.8, 79.8, 96.4, 127.6, 127.8, 129.7, 129.8, 134.3,
135.1, 136.1, 136.2, 140.3, 143.7; m/z (ES+) 1100 (M+ + 23, 4%),
239 (100).
1106, 1058, 1031, 836, 800; δH 0.04 (6H, s, 2
× SiCH3), 0.12
[9H, s, Si(CH3)3], 0.82-1.14 (2H, m, CH2Si), 0.94 [9H, s,
SiC(CH3)3], 1.04 (3H, d, J 6.3, 9-H3), 1.11 [9H, s, SiC(CH3)3],
4.2.4
(2E,5R,7R,8R)-1,8-Bis-tert-butyldiphenylsilyloxy-3-
1.54-1.66 (1H, m, 6-H), 1.72 (1H, ddd, J 13.6, 10.0, 3.3, 6-H
2.49 (1H, dd, J 14.2, 4.1, 4-H), 2.78 (1H, dd, J 14.4, 8.2, 4-H
′
′
),
),
tributylstannyl-5-triethylsilyloxy-7-(2-
trimethylsilylethoxymethoxy)non-2-ene (10). Following the
procedure outlined for the preparation of silyl ether 9, imidazole
(335 mg, 4.92 mmol), tert-butyldiphenylsilyl chloride (640 µl,
2.46 mmol) and alcohol 8 (1.97 g), after chromatography (1:1:98,
ether:Et3N:light petroleum), gave the title compound 10 (2.22 g,
90% from 6), Rf = 0.79 (1:9, ether:light petroleum); νmax/cm-1
2954, 2926, 2857, 1462, 1426, 1376, 1250, 1106, 1059; δH −0.06
3.28 (1H, br. s, OH), 3.51 (1H, ddd, J 11.1, 9.5, 5.9, CHHCH2Si),
3.66-3.76 (2H, m, CHHCH2Si, 7-H), 3.97 (1H, dq, J 6.5, 5.6, 8-
H), 4.02-4.13 (1H, m, 5-H), 4.23 (2H, d, J 6.4, 1-H2), 4.52 and
4.58 (each 1H, d, J 6.9, OHCHO), 6.50 (1H, t, J 6.3, 2-H), 7.38-
7.48 (6H, m, ArH), 7.68-7.76 (4H, m, ArH); δC −4.9, −1.1, 1.3,
18.0, 18.3, 19.5, 26.2, 27.3, 36.3, 47.4, 61.4, 66.3, 66.8, 71.0,
79.7, 96.3, 101.1, 127.8, 127.9, 129.9, 130.0, 134.6, 136.1, 136.2,
143.4. The second fraction was the title compound 13 (34 mg,
50%), Rf = 0.31 (1:1, ether:light petroleum); δH 0.06 [9H, s,
Si(CH3)3], 0.85-1.03 (2H, m, CH2Si), 1.05 (3H, d, J 6.3, 9-H3),
1.10 [9H, s, SiC(CH3)3], 1.60 (1H, ddd, J 14.4, 10.2, 2.9, 6-H),
[9H, s, Si(CH3)3], 0.54 (6H, q, J 8.2, 3
m, CHHSi), 0.76 (1H, ddd, J 13.6, 11.5, 5.8, CHHSi) 0.86-1.12
[45H, m, 3 SiCH2CH3, 3 CH3, 3 SnCH2, 2 SiC(CH3)3, 9-
H3], 1.21-1.64 (14H, m, 6 CH2, 6-H2), 2.30-2.40 (2H, m, 4-H2),
3.24 (1H, ddd, J 11.3, 9.7, 6.0, CHHCH2Si), 3.48 (1H, ddd, J
× SiCH2), 0.54-0.68 (1H,
×
×
×
×
×
1.76 (1H, ddd, J 13.9, 10.4, 4.2, 6-H′), 2.42 (1H, dd, J 14.6, 2.1,